BRCA2 T2722R is a deleterious allele that causes exon skipping

American Journal of Human Genetics

Volumn 71, Issue 3, 2002, Pages 625-631

  Fackenthal, James D ^a   Cartegni, Luca ^b   Krainer, Adrian R ^b   Olopade, Olufunmilayo I ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b Watson School of Biological Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

ALLELE; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; EXON; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036724459     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/342192     Document Type: Article

References (41)

1. Risk models for familial ovarian and breast cancer
2. Listening to silence and understanding nonsense: Exonic mutations that affect splicing
3. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1
4. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
5. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
6. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium
7. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
8. Genetic testing for breast cancer susceptibility: Frequency of BRCA1 and BRCA2 mutations
9. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors
10. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer
11. BRCA1 and BRCA2 in breast cancer families from Wales: Moderate mutation frequency and two recurrent mutations in BRCA1
12. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes
13. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions
14. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins
15. BRCA1 mutations and breast cancer in the general population: Analyses in women before age 35 years and in women before age 45 years with first-degree family history
16. When cells stop making sense: Effects of nonsense codons on RNA metabolism in vertebrate cells
17. A BRCA1 nonsense mutation causes exon skipping
18. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families
19. An exon splice enhancer mutation causes autosomal dominant GH deficiency
20. Splicing of messenger RNA precursors
21. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
22. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
23. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions
24. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17
25. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
26. RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression
27. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy
28. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic
29. BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study
30. The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4 modulation of soluble CD44 concentrations by hormone and anti-hormone treatment in gynecological tumor cell lines
31. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
32. Nonsense-mediated decay of mRNA for the seleno-protein phospholipid hydroperoxide glutathione peroxidase is detectable in cultured cells but masked or inhibited in rat tissues
33. Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family
34. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
35. Population-based study of risk of breast cancer in carriers of BRCA2 mutation
36. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing
37. The association of nonsense codons with exon skipping
38. Global sequence diversity of BRCA2: Analysis of 71 breast cancer families and 95 control individuals of worldwide populations
39. Distinct functions of SR proteins in alternative pre-mRNA splicing
40. Evidence that translation reinitiation abrogates nonsense-mediated mRNA decay in mammalian cells
41. At least one intron is required for the nonsense-mediated decay of triosephosphate isomerase mRNA: A possible link between nuclear splicing and cytoplasmic translation